Omega Therapeutics, Inc. (OMGA)
NASDAQ: OMGA · Real-Time Price · USD
0.790
+0.030 (3.97%)
At close: Nov 20, 2024, 4:00 PM
0.810
+0.020 (2.56%)
Pre-market: Nov 21, 2024, 4:11 AM EST
Omega Therapeutics Stock Forecast
OMGA's stock price has decreased by -63.07% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Omega Therapeutics stock have an average target of 9.20, with a low estimate of 4.00 and a high estimate of 12. The average target predicts an increase of 1,064.26% from the current stock price of 0.79.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OMGA stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $4 | Buy | Maintains | $9 → $4 | +406.20% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +1,418.60% | Aug 15, 2024 |
| Wedbush | Wedbush | Buy Reiterates $12 | Buy | Reiterates | $12 | +1,418.60% | Aug 7, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $7 → $6 | Strong Buy | Maintains | $7 → $6 | +659.30% | Aug 7, 2024 |
| Raymond James | Raymond James | Buy Initiates $12 | Buy | Initiates | $12 | +1,418.60% | Jun 18, 2024 |
Financial Forecast
Revenue This Year
7.03M
from 3.09M
Increased by 127.25%
Revenue Next Year
3.84M
from 7.03M
Decreased by -45.43%
EPS This Year
-1.13
from -1.80
EPS Next Year
-0.93
from -1.13
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.4M | 8.8M | 94.0M | ||
| Avg | 7.0M | 3.8M | 39.5M | ||
| Low | 4.4M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 235.8% | 25.4% | 2,350.3% | ||
| Avg | 127.2% | -45.4% | 930.7% | ||
| Low | 42.5% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.80 | -0.48 | -0.29 | ||
| Avg | -1.13 | -0.93 | -0.62 | ||
| Low | -1.25 | -1.25 | -0.78 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.